📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Towards utilizing VH single-domain-oligonucleotide conjugates as carriers for oligonucleotide therapeutics into tissue and cellular targets (2024)

First Author: Lustgarten O L

Attributed to: Nucleic Acid Therapy Accelerator (NATA) funded by SPF

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract